miSignal cancer risk screening follow-up study

miSignal cancer risk screening follow-up study - miSignal cancer risk screening follow-up study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046925

Enrollment

50000

Registered

2022-02-16

Start date

2022-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, Breast cancer, Esophageal cancer, Stomach cancer, Pancreatic cancer, Colon cancer, Ovarian cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. miSignal users 2. The age of 20 years and above 3. Obtained written consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Pregnant woman 2. Subjects who have a history of cancer 3. Subjects whom the principal investigator evaluates unsuitable to participate in this study for any other reason.

Design outcomes

Primary

Measure	Time frame
Cancer detection rate and accuracy (sensitivity and specificity) of miSignal	—

Secondary

Measure	Time frame
Cancer detection rate and accuracy (sensitivity and specificity) in combination with other cancer screening methods and miSignal.	—

Countries

Japan

Contacts

Public ContactYumi Nishiyama

Craif Inc. Clinical research office

clinicaltrial@craif.com03-6801-8334

Outcome results